Key result
Dapagliflozin alleviates radiation-induced cardiotoxicity by improving oxidative status and autophagy in preclinical model.
Why the study?
Cardiovascular complications are a major mortality-associated consequence of radiotherapy in breast and lung cancer patients, and the cardioprotective mechanisms of dapagliflozin in radiation-induced cardiotoxicity are not fully understood.
Does dapagliflozin mitigate radiation-induced cardiotoxicity in a rat model?
Does dapagliflozin mitigate radiation-induced cardiotoxicity in a rat model?
Dapagliflozin confers cardioprotection against radiation-induced injury in a rat model by reducing oxidative stress, modulating AMPK-mediated autophagy, and preventing apoptosis.
Cardiovascular complications are a major, mortality-associated consequence of radiotherapy in breast and lung cancer patients. Dapagliflozin (DAPA), a sodium-glucose co-transporter 2 inhibitor, has recently exhibited significant cardioprotective properties in cancer patients. The present study evaluated the cardioprotective efficacy and the underlying molecular mechanisms of DAPA in a rat model of radiation-induced cardiotoxicity. Male Sprague-Dawley rats were randomized into four groups: the first served as control; the second received DAPA (1 mg/kg, p.o. for 28 days); the third and fourth were exposed to 15 Gy acute thoracic γ-irradiation, with the fourth group receiving DAPA for 28 days post-irradiation. The deleterious effect of radiation on cardiac tissue was evidenced by marked histopathological alterations, increased heart index, elevated serum CK-MB levels, alongside ECG changes, including bradycardia and tall T waves, all of which were significantly alleviated by DAPA treatment. DAPA exhibited significant cardiac antioxidant properties, as reflected by reduced MDA and increased reduced glutathione levels. Mechanistically, DAPA mediated AMPK phosphorylation and enhanced autophagy-related responses following irradiation, as evidenced by increased expression of autophagy proteins (LC3, Beclin-1), upregulating the transcription of autophagy-related genes (ATG5, ATG7, ATG12), and decreased SQSTM1/p62 accumulation. This autophagic activation was accompanied by a blockage of intrinsic cardiomyocyte apoptosis triggered by radiation, as shown by decreased transcription of p53 and Bax while increased Bcl2, resulted in a reduced Bax/Bcl2 ratio and suppressed cleaved caspase-3 expression. In conclusion, DAPA confers cardio-protection against radiation injury by improving oxidative status and modulating the balance between apoptosis and adaptive autophagy, accompanied by increased AMPK phosphorylation.
No takes yet. Share an insight, caveat, or question.
El‐Sabbagh et al. (2026) studied Radiation-induced cardiotoxicity. Dapagliflozin vs. Control was evaluated on Radiation-induced cardiotoxicity (histopathological alterations, CK-MB levels, ECG changes, oxidative status, and apoptosis). Dapagliflozin (1 mg/kg for 28 days) significantly alleviated radiation-induced cardiotoxicity in rats by improving oxidative status and modulating AMPK-regulated autophagy and apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: